Suppr超能文献

从人血浆中部分纯化并鉴定一种蛋白酶,该蛋白酶可将血管性血友病因子切割成体内蛋白水解产生的片段。

Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.

作者信息

Furlan M, Robles R, Lämmle B

机构信息

Central Hematology Laboratory of the University, Inselspital, Bern, Switzerland.

出版信息

Blood. 1996 May 15;87(10):4223-34.

PMID:8639781
Abstract

Proteolytic cleavage of von Willebrand factor (vWF) takes place in the circulating blood of healthy subjects and is increased in some patients with von Willebrand disease type 2A. The hemostatically active large vWF multimers are degraded to smaller less active forms. It has been suggested that the polypeptide subunit of vWF is cleaved at the peptide bond 842Tyr-843Met. We purified (approximately 10,000-fold) from human plasma a vWF-degrading protease, using chelating Sepharose, hydrophobic interaction chromatography, and gel filtration. The enzyme was found to be virtually absent in the platelet lysates obtained by repeated freezing and thawing. The proteolytic activity was associated with a high molecular weight protein (approximately 300 kD) as judged by gel filtration and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. vWF was resistant against the protease in a neutral buffer at physiological ionic strength but became degraded at low salt concentration or in the presence of 1 mol/L urea. No degradation of human fibrinogen, bovine serum albumin, of calf skin collagen by the purified protease was noted under the same experimental conditions. Proteolytic activity showed a pH optimum at 8 to 9 and was strongly inhibited by chelating agents, whereas only slow inhibition was observed with N-ethylmaleimide. There was no inhibition by iodoacetamide, leupeptin, or serine protease inhibitors. The best peptidyl diazomethyl ketone inhibitor was Z-Phe-Phe-CHN2. Activation by divalent metal ions was found to increase in the following order: Zn2+ approximately Cu2+ approximately CD2+ approximately Ni2+ approximately Co2+ <Mn2+ <Mg2+ <Ca2+ <Sr2+ <Ba2+. The observed properties of the vWF-degrading enzyme differ from those of all other hitherto described proteases. Purified vWF was incubated with the protease, and the degraded material subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis after disulfide reduction. The size, amino acid composition, and amino terminal sequence of the reduced fragments confirmed that the peptide bond 842Tyr-843Met had been cleaved, ie, the same bond that has been proposed to be cleaved in vivo.

摘要

血管性血友病因子(vWF)的蛋白水解切割在健康受试者的循环血液中发生,并且在一些2A型血管性血友病患者中有所增加。具有止血活性的大vWF多聚体被降解为活性较低的较小形式。有人提出vWF的多肽亚基在肽键842Tyr - 843Met处被切割。我们使用螯合琼脂糖、疏水相互作用色谱和凝胶过滤从人血浆中纯化了(约10000倍)一种vWF降解蛋白酶。通过反复冻融获得的血小板裂解物中几乎没有发现这种酶。通过凝胶过滤和十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳判断,蛋白水解活性与一种高分子量蛋白质(约300 kD)相关。在生理离子强度的中性缓冲液中,vWF对该蛋白酶具有抗性,但在低盐浓度或存在1 mol/L尿素的情况下会被降解。在相同实验条件下,未观察到纯化的蛋白酶对人纤维蛋白原、牛血清白蛋白或小牛皮肤胶原蛋白的降解。蛋白水解活性在pH 8至9时表现出最佳值,并且受到螯合剂的强烈抑制,而用N - 乙基马来酰亚胺仅观察到缓慢抑制。碘乙酰胺、亮抑酶肽或丝氨酸蛋白酶抑制剂没有抑制作用。最佳的肽基重氮甲基酮抑制剂是Z - Phe - Phe - CHN2。发现二价金属离子的激活作用按以下顺序增加:Zn2+≈Cu2+≈Cd2+≈Ni2+≈Co2+ <Mn2+ <Mg2+ <Ca2+ <Sr2+ <Ba2+。观察到的vWF降解酶的特性与迄今描述的所有其他蛋白酶的特性不同。将纯化的vWF与蛋白酶一起孵育,降解后的物质在二硫键还原后进行十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳。还原片段的大小、氨基酸组成和氨基末端序列证实肽键842Tyr - 843Met已被切割,即与体内推测被切割的键相同。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验